Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA box-binding protein-associated factor RNA polymerase I subunit C (TAF1C) is a core component of the SL1 complex, which is essential for the initiation of transcription by RNA polymerase I. TAF1C, the largest SL1-specific TBP-associated factor, interacts with the TATA-binding protein (TBP) and with other TAFs to form the SL1 complex, which binds to the core promoter of ribosomal RNA genes, thereby positioning RNA polymerase I correctly for transcription initiation. This process is critical for ribosomal RNA (rRNA) synthesis, a fundamental step for ribosome biogenesis and cellular protein synthesis. TAF1C also aids in stabilizing nucleolar transcription factor UBTF on rDNA and facilitates the recruitment of RNA polymerase I via specific protein interactions. Disruption of TAF1C function is implicated in diseases involving impaired ribosome biogenesis or cell growth, such as cancer and certain developmental disorders[1][2][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA box-binding protein-associated factor RNA polymerase I subunit C (TAF1C).